InsiderClue
← All stocks

Disc Medicine, Inc.

IRON Scheduled selling only
CIK 0001816736 #1749 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$9.77M
$4.50M on a plan · $5.27M straight out of an exercise
Sold at will
$0.00
0 of 21 sales
Net
−$9.77M
$0.00 against sales at will

By person

11 insiders · 22 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Bitterman Kevin
Director
—
$6.41M (16) scheduled
−$6.41M
27,440
0.0715%
$1.92M
−94.8%
Quisel John D
Chief Executive Officer
—
$2.61M (3) scheduled
−$2.61M
262,064
0.6826%
$18.37M
+263.6%
Yu Jonathan Yen-Wen
Chief Operating Officer
—
$755.85K (2) scheduled
−$755.85K
54,324
0.1415%
$3.81M
+199.1%
AI DMI LLC entity
10% owner
—
—
—
2,814,379
7.33%
$197.32M
−20.9%
ORBIMED ADVISORS LLC entity
Director
—
—
—
186,541
0.4859%
$13.08M
−66.5%
Ashiya Mona
Director
—
—
—
186,541
0.4859%
$13.08M
−66.5%
Stephenson Pamela
Chief Commercial Officer
—
—
—
80,998
0.2110%
$5.68M
+120.9%
Savage William Jacob
Chief Medical Officer
—
—
—
79,480
0.2070%
$5.57M
+96.7%
Franchi Jean M.
Chief Financial Officer
—
—
—
64,333
0.1676%
$4.51M
+75.5%
Khara Rahul
Chief Legal Officer
—
—
—
52,324
0.1363%
$3.67M
+241.1%
White William Richard
Director
—
—
—
0
0.0000%
$0.00
—

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Bitterman Kevin
11 Sep 2026
Director
Sold after exercise
27,136
$70.11
$1.90M
Yu Jonathan Yen-Wen
25 Aug 2026
Chief Operating Officer
Sold after exercise
8,796
$83.12
$731.09K
Yu Jonathan Yen-Wen
24 Aug 2026
Chief Operating Officer
Sold after exercise
300
$82.53
$24.76K
Quisel John D
17 Aug 2026
Chief Executive Officer
Sold after exercise
11,888
$79.84
$949.16K
Quisel John D
17 Aug 2026
Chief Executive Officer
Sold after exercise
12,712
$79.20
$1.01M
Quisel John D
17 Aug 2026
Chief Executive Officer
Sold after exercise
8,400
$78.11
$656.09K
Show all 22 transactions →

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 6
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 105,232
History held since 19 Oct 2020